A potential interaction between anti-LtxA IgM antibodies and anti-CCP is also suggested in patients with early RA, which may imply a role of Aa in enhancing the immune response to citrullinated proteins at early stages of the disease. This evidence concerns the gene TEAD1 and rheumatoid arthritis.